Efferalganodis Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Efferalganodis
V
- valoctocogene roxaparvovec
- Vanatol LQ (acetaminophen / butalbital / caffeine)
- Vanatol S (acetaminophen / butalbital / caffeine)
- Vaxneuvance (pneumococcal 15-valent conjugate vaccine)
- Veklury (remdesivir)
- Velivet (desogestrel / ethinyl estradiol)
- vemurafenib
- VeraRing (ethinyl estradiol / etonogestrel)
- VESIcare (solifenacin)
- VESIcare LS (solifenacin)
- Vestura (drospirenone / ethinyl estradiol)
- Vi-Atro (atropine / diphenoxylate)
- Victoza (liraglutide)
- Vienva (ethinyl estradiol / levonorgestrel)
- Vilamit MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Vilevev MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Viorele (desogestrel / ethinyl estradiol)
- VisRx Dose Pack (chlorpheniramine / methscopolamine / pseudoephedrine)
- Vitetal (atropine / hyoscyamine / phenobarbital / scopolamine)
- Vivacaine (bupivacaine / epinephrine)
- Vivitrol (naltrexone)
- Volnea (desogestrel / ethinyl estradiol)
- Vtol LQ (acetaminophen / butalbital / caffeine)
- Vyfemla (ethinyl estradiol / norethindrone)
- VyLibra (ethinyl estradiol / norgestimate)
- Vyndamax (tafamidis)
- Vyndaqel (tafamidis)
More about Efferalganodis (acetaminophen)
- Check interactions
- Compare alternatives
- Latest FDA alerts (16)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous analgesics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.